Page 96 - Amgen News Today

Raymond James has resumed coverage of Amgen Inc AMGN, noting a diversified portfolio where Amgen has a strong presence that can help drive solid, sustainable…

CPA Asset Management LLC cut its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,380 shares of the medical research company’s stock after selling 146 shares during the period. CPA Asset […]

CPA Asset Management LLC cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,380 shares of the medical research company’s stock after selling 146 shares during the quarter. CPA Asset Management LLC’s holdings in Amgen were worth $686,000 as of […]

Schechter Investment Advisors LLC lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,210 shares of the medical research company’s stock after selling 190 shares during the quarter. […]

Sawyer & Company Inc raised its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 184.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 45,605 shares of the medical research company’s stock after acquiring an additional 29,570 shares during […]

Monarch Capital Management Inc. bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 710 shares of the medical research company’s stock, valued at approximately $204,000. Other hedge funds have also modified […]

Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight.

Sawyer & Company Inc increased its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 184.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 45,605 shares of the medical research company’s stock after buying an additional 29,570 shares during the period. Amgen accounts for approximately 5.6% […]

The drug is used to relieve the signs and symptoms of rheumatoid arthritis and osteoarthritis while decreasing the risk of developing ulcers people may experience from ibuprofen alone.

A new seven-story, life science building is moving forward in South City, making it the newest addition to the biotech hub and demonstrating the sector’s persistent growth amid an otherwise